This is feed that updates daily with CME offerings from JAMA, American College of Surgeons, and UC CMEs. Please follow the links for each to learn more.
Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?
HEALTH CARE ECONOMICS, INSURANCE, PAYMENT | 1 Credit | CME | Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout? | JAMA Oncology Read More
Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?
HEALTH CARE ECONOMICS, INSURANCE, PAYMENT | 1 Credit | CME | Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout? | JAMA OncologyRead More
Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout?
HEALTH CARE ECONOMICS, INSURANCE, PAYMENT | 1 Credit | CME | Independent Oncology Practices in the COVID-19 Era—Does US Cancer Care Need a Bailout? | JAMA Oncology Read More
2020 New York Chapter Annual Meeting and Educational Event
Webinar
Wednesday, November 18, 2020, 6 – 8pm
Location City: Virtual
Location Country: United States
Event Category: ACS Chapter
Contact Name: Babette Atkins
Contact Email: bgrey@nysurgeon.org
Contact Phone: (518) 598-7755
Event Website: nysurgeon.org…
More info: nysurgeon.org… Read More
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries
CERVICAL CANCER | 1 Credit | CME | Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries | JAMA Read More
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries
CERVICAL CANCER | 1 Credit | CME | Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries | JAMARead More
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries
CERVICAL CANCER | 1 Credit | CME | Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries | JAMA Read More
Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life
CARDIOLOGY | 33m 24s | Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life | JAMA Internal Medicine Read More
Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life
CARDIOLOGY | 33m 24s | Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life | JAMA Internal MedicineRead More
Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life
CARDIOLOGY | 33m 24s | Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life | JAMA Internal Medicine Read More
US Food and Drug Administration Support for Oncology Drug Development During COVID-19
HEALTH CARE POLICY | 1 Credit | CME | US Food and Drug Administration Support for Oncology Drug Development During COVID-19 | JAMA Oncology Read More
US Food and Drug Administration Support for Oncology Drug Development During COVID-19
HEALTH CARE POLICY | 1 Credit | CME | US Food and Drug Administration Support for Oncology Drug Development During COVID-19 | JAMA OncologyRead More
US Food and Drug Administration Support for Oncology Drug Development During COVID-19
HEALTH CARE POLICY | 1 Credit | CME | US Food and Drug Administration Support for Oncology Drug Development During COVID-19 | JAMA Oncology Read More
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial
LIFESTYLE BEHAVIORS | 1 Credit | CME | Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: | A Randomized Clinical Trial | JAMA Read More
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial
LIFESTYLE BEHAVIORS | 1 Credit | CME | Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: | A Randomized Clinical Trial | JAMARead More
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial
LIFESTYLE BEHAVIORS | 1 Credit | CME | Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: | A Randomized Clinical Trial | JAMA Read More
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
GASTRIC CANCER | 1 Credit | CME | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: | The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA Oncology Read More
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
GASTRIC CANCER | 1 Credit | CME | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: | The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA OncologyRead More
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
GASTRIC CANCER | 1 Credit | CME | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: | The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA Oncology Read More
Association of Measurable Residual Disease With Survival in Patients With Acute Myeloid Leukemia
HEMATOLOGY | 13m 59s | Association of Measurable Residual Disease With Survival in Patients With Acute Myeloid Leukemia | JAMA Oncology Read More
